CENTESSA PHARMACEUTICALS (260) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.148x

Based on the latest financial reports, CENTESSA PHARMACEUTICALS (260) has a cash flow conversion efficiency ratio of -0.148x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-72.22 Million ≈ $-84.44 Million USD) by net assets (€487.35 Million ≈ $569.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 260 market cap overview for the company's overall valuation and market capitalisation.

CENTESSA PHARMACEUTICALS - Cash Flow Conversion Efficiency Trend (2022–2025)

This chart illustrates how CENTESSA PHARMACEUTICALS's cash flow conversion efficiency has evolved over time, based on yearly financial data. View CENTESSA PHARMACEUTICALS stock quote for real-time trading data and today's change.

CENTESSA PHARMACEUTICALS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CENTESSA PHARMACEUTICALS ranked by their cash flow conversion efficiency. Review 260 financial flexibility index to assess the company's free cash flow relative to its total liabilities.

Company	Cash Flow Conversion Efficiency
Cirrus Logic Inc NASDAQ:CRUS	0.029x
GXO Logistics Inc NYSE:GXO	0.025x
PTC Therapeutics Inc NASDAQ:PTCT	0.327x
Kanzhun Ltd ADR NASDAQ:BZ	0.066x
D-Wave Quantum Inc. NYSE:QBTS	-0.040x
Joby Aviation NYSE:JOBY	-0.074x
Colgate Palmolive (India) Limited NSE:COLPAL	0.838x
SBM Offshore N.V. AS:SBMO	0.362x

Annual Cash Flow Conversion Efficiency for CENTESSA PHARMACEUTICALS (2022–2025)

The table below shows the annual cash flow conversion efficiency of CENTESSA PHARMACEUTICALS from 2022 to 2025. Also see 260 asset base for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€526.86 Million ≈ $615.96 Million	€-193.82 Million ≈ $-226.59 Million	-0.368x	-3.99%
2024-12-31	€401.55 Million ≈ $469.45 Million	€-142.06 Million ≈ $-166.08 Million	-0.354x	+47.88%
2023-12-31	€236.24 Million ≈ $276.19 Million	€-160.34 Million ≈ $-187.46 Million	-0.679x	-13.77%
2022-12-31	€336.17 Million ≈ $393.02 Million	€-200.55 Million ≈ $-234.46 Million	-0.597x	--

About CENTESSA PHARMACEUTICALS

F:260 Germany

Market Cap

$6.26 Billion

€5.35 Billion EUR

Market Cap Rank

#3381 Global

#638 in Germany

Share Price

€34.60

Change (1 day)

+0.00%

52-Week Range

€18.00 - €34.60

All Time High

€34.60